in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—26 March 2014
3:55 AM MDT | March 26, 2014 | Deepti Ramesh
AMRI to acquire API firm Cedarburg Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Hauser Pharmaceuticals (Grafton, WI), for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million. Cedarburg is a contract developer and manufacturer of technically complex active pharmaceutical ingredients (APIs) for both generic and branded customers. The transaction is expected to close in early April. Cedarburg's forecasted...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee